Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • OnTheHouse integrates Openn Offers after customers complain of missing price info and competition
    • News

    OnTheHouse integrates Openn Offers after customers complain of missing price info and competition

    No more under-the-table deals, greasing palms, and paying more than you should, only to discover later that you got duped and were embarrassed to do anything about it. PropTech company Openn (ASX: OPN), through its private treaty platform Openn Offers, is attempting to enable fair market exchange between property buyers and sellers. In doing so,

    Read More
    Public
  • The ugly side of the beauty business: McPherson’s to lay off 40 employees following poor year
    • News

    The ugly side of the beauty business: McPherson’s to lay off 40 employees following poor year

    A streamlined portfolio, new leadership, and layoffs—Aussie health, wellness and beauty products brand McPherson’s (ASX: MCP), the brand behind Manicare, Lady Jayne and Fusion Health, has begun damage control after its FY23 financials painted a worrying picture for shareholders. The Company’s new strategy will focus on its higher margin and higher growth categories where McPherson’s

    Read More
    Public
  • Shares skyrocket higher after US CPI comes in lower than expected
    • Market Update

    Shares skyrocket higher after US CPI comes in lower than expected

    The XJO is expected to open higher this morning following an extraordinary move higher in the U.S overnight. Their move was largely on the back of a lower CPI reading that vindicated pundits whom believe the Fed tightening cycle is at an end. Their futures are also in the green. With the U.S crystalising their

    Read More
    Public
  • MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract
    • News

    MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract

    Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone.  For countries like Estonia and the US, it entailed boosting telehealth services. For

    Read More
    Public
  • First patients dosed in Phase 2 clinical trials to tackle Parkinson’s disease
    • News

    First patients dosed in Phase 2 clinical trials to tackle Parkinson’s disease

    Parkinson’s UK, in collaboration with Australian researchers, has taken a major step towards preventing the development of Parkinson’s disease with the first Australian patient in a Phase 2 clinical trial having been dosed with PXS-4708, a novel drug aimed at tackling  Parkinson’s before its onset, along with other neurodegenerative disorders. The multi-national trial was initiated

    Read More
    Public
  • Catapult generates positive cash flow for the first time since 2021, becomes official supplier for NASCAR
    • News

    Catapult generates positive cash flow for the first time since 2021, becomes official supplier for NASCAR

    After months of investing in new products and signing new contracts, sports performance analytics company Catapult (ASX: CAT) has scored big. For the first time since September 2021, the Company has generated positive free cash flow amounting to $2.2 million. And that is just scratching the surface. Catapult’s total revenue grew to $77 million, up

    Read More
    Public
  • «
  • ‹
  • 153
  • 154
  • 155
  • 156
  • 157
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.